Discussion topics will include:

• Genomics England’s clinical and research strategy: Improving diagnostic yield for rare disease and cancer patients in the NHS; and how the world’s largest whole genome research library is advancing biopharma and academic research, as well as diagnostic discovery, for rare and complex disease patients in the NHS.
• How machine learning is driving hypothesis free insight into clinical diagnosis and prognosis, and into mechanism of action in research
• Future technologies and the next wave genomics science in cancer and rare disease.